AFYA Logo

Afya Ltd (AFYA) Stock Forecast & Price Prediction

Live AFYA Stock Price & Analysis

Home โ€บ Stocks โ€บ Brazil | NASDAQ | Consumer Defensive | Education & Training Services

$16.60

+0.02 (0.12%)

12 Month Price Forecast For AFYA

$16.60
Current Price
$1.51B
Market Cap
9 Ratings
Buy 3
Hold 3
Sell 3
Wall St Analyst Ratings

Distance to AFYA Price Forecasts

+49.8%
To High Target of $24.87
+14.6%
To Median Target of $19.03
-15.9%
To Low Target of $13.96

AFYA Price Momentum

+4.4%
1 Week Change
+11.0%
1 Month Change
-21.0%
1 Year Change
+4.5%
Year-to-Date Change
-25.4%
From 52W High of $22.24
+14.3%
From 52W Low of $14.52

๐Ÿค” Considering Afya (AFYA)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 5:42 PM UTC

AFYA Analyst Ratings & Price Targets

Based on our analysis of 8 Wall Street analysts, AFYA has a neutral consensus with a median price target of $19.03 (ranging from $13.96 to $24.87). The overall analyst rating is Hold (5.8/10). Currently trading at $16.60, the median forecast implies a 14.6% upside. This outlook is supported by 3 Buy, 3 Hold, and 3 Sell ratings.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

AFYA Analyst Consensus

3
Buy
3
Hold
3
Sell

AFYA Price Target Range

Low
$13.96
Average
$19.03
High
$24.87
Current: $16.60

Latest AFYA Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for AFYA.

Date Firm Analyst Rating Change Price Target
Jan 31, 2025 Citigroup Leandro Bastos Sell Downgrade $15.00
Jan 17, 2025 JP Morgan Marcelo Santos Neutral Maintains $20.50
Dec 3, 2024 Goldman Sachs Gustavo Miele Sell Initiates $16.00
Aug 30, 2024 UBS Andre Salles Neutral Initiates $19.50
Jun 21, 2024 Morgan Stanley Mauricio Cepeda Equal-Weight Maintains $19.00
Jan 22, 2024 Morgan Stanley Javier Martinez Equal-Weight Downgrade $23.00
Nov 27, 2023 JP Morgan Marcelo Santos Neutral Downgrade $23.00
Oct 13, 2023 Morgan Stanley Javier Martinez Overweight Upgrade $20.50
Nov 22, 2022 Credit Suisse Mauricio Cepeda Outperform Maintains $18.00
Aug 23, 2022 Credit Suisse Outperform Upgrade $0.00
Apr 8, 2022 Credit Suisse Mauricio Cepeda Outperform Upgrade $19.00
Mar 7, 2022 UBS Maria Tereza Azevedo Buy Maintains $21.00
Jul 21, 2021 Morgan Stanley Javier Martinez Equal-Weight Downgrade $28.50
Apr 15, 2021 UBS Buy Upgrade $0.00
Feb 4, 2021 JP Morgan Overweight Upgrade $0.00
Oct 19, 2020 JP Morgan Neutral Downgrade $0.00
Sep 28, 2020 Goldman Sachs Buy Upgrade $0.00
Aug 19, 2020 Credit Suisse Neutral Initiates $0.00
May 20, 2020 UBS Neutral Downgrade $0.00
May 5, 2020 JP Morgan Overweight Maintains $24.50

Stocks Similar to Afya Ltd

The following stocks are similar to Afya based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Afya Ltd (AFYA) Financial Data

Afya Ltd has a market capitalization of $1.51B with a P/E ratio of 15.1x. The company generates $530.58M in trailing twelve-month revenue with a 18.0% profit margin.

Revenue growth is +13.7% quarter-over-quarter, while maintaining an operating margin of +28.5% and return on equity of +15.3%.

Valuation Metrics

Market Cap $1.51B
Enterprise Value $602.21M
P/E Ratio 15.1x
PEG Ratio 9.9x
Price/Sales 0.5x

Growth & Margins

Revenue Growth (YoY) +13.7%
Gross Margin +61.5%
Operating Margin +28.5%
Net Margin +18.0%
EPS Growth +91.1%

Financial Health

Cash/Price Ratio +48.3%
Current Ratio 1.5x
Debt/Equity 67.3x
ROE +15.3%
ROA +7.1%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Afya Ltd logo

Afya Ltd (AFYA) Company Overview

About Afya Ltd

What They Do

Provides medical education and digital health services.

Business Model

The company generates revenue through offering a diverse range of educational products and services, including medical schools, residency courses, and health science programs. It also monetizes its digital health services through subscription models for its mobile app and online portal, which assist healthcare professionals and students with clinical decision-making.

Additional Information

Afya operates in three segments: Undergrad, Continuing Education, and Digital Services, and offers a variety of programs across multiple health and academic disciplines. The company also provides practice management software and various health-related digital solutions, expanding its reach in the healthcare sector. Founded in 1999 and headquartered in Brazil, Afya is well-positioned in the growing medical education market.

Company Information

Sector

Consumer Defensive

Industry

Education & Training Services

Employees

0

CEO

Country

Brazil

IPO Year

2019

Afya Ltd (AFYA) Latest News & Analysis

AFYA stock latest news image
Quick Summary

Afya Limited has signed a share purchase agreement to acquire 100% of Faculdade Masterclass Ltda in Contagem, Brazil, through its subsidiary Afya Participaรงรตes S.A.

Why It Matters

Afya's acquisition of Faculdade Masterclass expands its market presence and educational offerings in Brazil, potentially enhancing revenue growth and competitive positioning.

Source: Business Wire
Market Sentiment: Neutral
AFYA stock latest news image
Quick Summary

AFYA has entered into a share purchase agreement to acquire 100% of FUNIC.

Why It Matters

AFYA's acquisition of FUNIC may enhance its market position, increase revenue streams, and improve growth prospects, potentially influencing stock performance and investor sentiment.

Source: Zacks Investment Research
Market Sentiment: Positive
AFYA stock latest news image
Quick Summary

Afya reported 12% organic revenue growth and 16% overall growth in Q3 2024, boosted by the Unidom acquisition. Adjusted EBITDA margin rose by 300bps, with net income up 68% YoY. P/E is 11x.

Why It Matters

Afya's strong revenue growth and improved margins indicate robust business performance. Attractive valuation and growth prospects enhance appeal for potential investment returns.

Source: Seeking Alpha
Market Sentiment: Positive
AFYA stock latest news image
Quick Summary

Afya Limited (Nasdaq: AFYA) reported its Q3 2024 financial results, with figures presented in Brazilian Reais and compliant with IFRS. Further details on performance are expected.

Why It Matters

Afya Limited's Q3 2024 financial results indicate its performance trajectory, impacting investor sentiment and stock valuation in the medical education and practice solutions sector.

Source: Business Wire
Market Sentiment: Neutral
AFYA stock latest news image
Quick Summary

Afya (AFYA) reported Q3 earnings of $0.32 per share, below the Zacks estimate of $0.36. This marks an increase from $0.28 per share in the same period last year.

Why It Matters

Afya's earnings miss raises concerns about growth potential and market performance, potentially impacting share prices and investor sentiment.

Source: Zacks Investment Research
Market Sentiment: Negative
AFYA stock latest news image
Quick Summary

Afya Limited will report its Q3 2024 financial results on November 13, 2024, after market close, followed by a conference call at 5 PM EST.

Why It Matters

Afya Limited's upcoming financial results announcement on November 13, 2024, will provide insights into its performance and growth potential, influencing investor sentiment and stock valuation.

Source: Business Wire
Market Sentiment: Neutral

Frequently Asked Questions About AFYA Stock

What is Afya Ltd's (AFYA) stock forecast for 2025?

Based on our analysis of 8 Wall Street analysts, Afya Ltd (AFYA) has a median price target of $19.03. The highest price target is $24.87 and the lowest is $13.96.

Is AFYA stock a good investment in 2025?

According to current analyst ratings, AFYA has 3 Buy ratings, 3 Hold ratings, and 3 Sell ratings. The stock is currently trading at $16.60. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for AFYA stock?

Wall Street analysts predict AFYA stock could reach $19.03 in the next 12 months. This represents a 14.6% increase from the current price of $16.60. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Afya Ltd's business model?

The company generates revenue through offering a diverse range of educational products and services, including medical schools, residency courses, and health science programs. It also monetizes its digital health services through subscription models for its mobile app and online portal, which assist healthcare professionals and students with clinical decision-making.

What is the highest forecasted price for AFYA Afya Ltd?

The highest price target for AFYA is $24.87 from at , which represents a 49.8% increase from the current price of $16.60.

What is the lowest forecasted price for AFYA Afya Ltd?

The lowest price target for AFYA is $13.96 from at , which represents a -15.9% decrease from the current price of $16.60.

What is the overall AFYA consensus from analysts for Afya Ltd?

The overall analyst consensus for AFYA is neutral. Out of 8 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 3 as Sell, with a median price target of $19.03.

How accurate are AFYA stock price projections?

Stock price projections, including those for Afya Ltd, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.